| Ident. | Authors (with country if any) | Title |
|---|
| 000032 |
Elise Klement [France] ; Palokinam Pitche [Togo] ; Eric Kendjo [France] ; Assétina Singo [Togo] ; Stéphane D'Almeida [Togo] ; Folly Akouete [France] ; Yawo Akpaloo [Togo] ; Kokou Tossa [Togo] ; Serge Prince-Agbodjan [France] ; Akouda Patassi [Togo] ; Eric Caumes [France] | Effectiveness of Co-trimoxazole to Prevent Plasmodium falciparum Malaria in HIV-Positive Pregnant Women in Sub-Saharan Africa: An Open-Label, Randomized Controlled Trial |
| 000212 |
Andrew J. Nunn [Royaume-Uni, Zambie] ; Peter B. Mwaba [Zambie, Royaume-Uni] ; Chifumbe Chintu [Zambie, Royaume-Uni] ; Angela M. Crook [Royaume-Uni, Zambie] ; Janet H. Darbyshire [Royaume-Uni, Zambie] ; Yusuf Ahmed [Zambie, Royaume-Uni] ; Alimuddin I. Zumla [Zambie, Royaume-Uni] | Randomised, placebo-controlled trial to evaluate co-trimoxazole to reduce mortality and morbidity in HIV-infected post-natal women in Zambia (TOPAZ) |
| 000296 |
Darlington M. Mwenya [Zambie, Royaume-Uni] ; Bambos M. Charalambous [Royaume-Uni] ; Patrick P. J. Phillips [Royaume-Uni] ; James C. L. Mwansa [Zambie] ; Sarah L. Batt [Royaume-Uni] ; Andrew J. Nunn [Royaume-Uni] ; Sarah Walker [Royaume-Uni] ; Diana M. Gibb [Royaume-Uni] ; Stephen H. Gillespie [Royaume-Uni] | Impact of Cotrimoxazole on Carriage and Antibiotic Resistance of Streptococcus pneumoniae and Haemophilus influenzae in HIV-Infected Children in Zambia |
| 000340 |
A. D. Harries [France, Royaume-Uni] ; R. Zachariah [Belgique] ; S. D. Lawn [Royaume-Uni, Afrique du Sud] | Providing HIV care for co-infected tuberculosis patients : a perspective from sub-Saharan Africa |
| 000420 |
Mairin Ryan [Irlande (pays)] ; Susan Griffin [Royaume-Uni] ; Bona Chitah [Zambie] ; A. Sarah Walker [Royaume-Uni] ; Veronica Mulenga [Zambie] ; Donald Kalolo [Zambie] ; Neil Hawkins [Royaume-Uni] ; Concepta Merry [Irlande (pays)] ; Michael G. Barry [Irlande (pays)] ; Chifumbe Chintu [Zambie] ; Mark J. Sculpher [Royaume-Uni] ; Diana M. Gibb [Royaume-Uni] | The cost-effectiveness of cotrimoxazole prophylaxis in HIV-infected children in Zambia |
| 000487 |
G. Martin-Blondel [France] ; M. Barry [France] ; L. Porte [France] ; F. Busato [France] ; P. Massip [France] ; F. Benoit-Vical [France] ; A. Berry [France] ; B. Marchou [France] | Impact de l'infection VIH sur l'infection palustre chez l'adulte |
| 000503 |
A. Sarah Walker [Royaume-Uni] ; Veronica Mulenga [Zambie] ; Deborah Ford [Royaume-Uni] ; Desire Kabamba [Zambie] ; Frederick Sinyinza [Zambie] ; Chipepo Kankasa [Zambie] ; Chifumbe Chintu [Zambie] ; Diana M. Gibb [Royaume-Uni] | The Impact of Daily Cotrimoxazole Prophylaxis and Antiretroviral Therapy on Mortality and Hospital Admissions in HIV-Infected Zambian Children |
| 000506 |
Rony Zachariah [Belgique] ; Anthony D. Harries [Malawi, Royaume-Uni] ; Chewe Luo [États-Unis] ; Gretchen Bachman [États-Unis] ; Stephen M. Graham [Malawi] | Scaling-up co-trimoxazole prophylaxis in HIV-exposed and HIV-infected children in high HIV-prevalence countries |
| 000539 |
Veronica Mulenga [Zambie] ; Deborah Ford [Royaume-Uni] ; A. Sarah Walker [Royaume-Uni] ; Darlington Mwenya [Zambie] ; James Mwansa [Zambie] ; Frederick Sinyinza [Zambie] ; Kennedy Lishimpi [Zambie] ; Andrew Nunn [Royaume-Uni] ; Stephen Gillespie [Royaume-Uni] ; Ali Zumla [Royaume-Uni] ; Chifumbe Chintu [Zambie] ; Diana M. Gibb [Royaume-Uni] | Effect of cotrimoxazole on causes of death, hospital admissions and antibiotic use in HIV-infected children |
| 000594 |
Siaka Toure [France, Côte d'Ivoire] ; Delphine Gabillard [France] ; André Inwoley [Côte d'Ivoire] ; Catherine Seyler [France, Côte d'Ivoire] ; Gwenola Gourvellec [Côte d'Ivoire] ; Xavier Anglaret [France, Côte d'Ivoire] | Incidence of neutropenia in HIV-infected African adults receiving co-trimoxazole prophylaxis : a 6-year cohort study in Abidjan, Côte d'Ivoire |
